Oral delivery systems for microparticles

• US 6,159,502 A
• Filed: 11/30/1992
• Issued: 12/12/2000
• Est. Priority Date: 04/02/1991
• Status: Expired due to Term

• Current Assignee: Access Pharmaceuticals Inc.
• Original Assignee: Biotech Australia Pty., Ltd.
• Inventors: Russell-Jones, Gregory John, Westwood, Steven William
• Primary Examiner(s): Kishore, Gollamudi S.
• Application Number:
  US07/956,003
• Time in Patent Office: 2,934 Days
• Field of Search: 424/450, 424/489, 424/491, 424/499, 428/402.2, 436/829
• US Class Current: 424/489
• CPC Class Codes: A61K 47/6931 the material constituting the nanoparticle being a polymer
• CPC Class Codes: A61K 9/167 with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface with further drug-free outer coating A61K9/5073
• CPC Class Codes: A61K 9/5138 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
• CPC Class Codes: A61K 9/5153 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: A61K 9/5169 Proteins, e.g. albumin, gelatin
• CPC Class Codes: Y10S 977/906 Drug delivery

Abstract

There are disclosed complexes and compositions for oral delivery of a substance or substances to the circulation or lymphatic drainage system of a host. The complexes of the invention comprise a microparticle coupled to at least one carrier, the carrier being capable of enabling the complex to be transported to the circulation or lymphatic drainage system via the mucosal epithelium of the host, and the microparticle entrapping or encapsulating, or being capable of entrapping or encapsulating, the substance(s). Examples of suitable carriers are mucosal binding proteins, bacterial adhesins, viral adhesins, toxin binding subunits, lectins, Vitamin B₁₂ and analogues or derivatives of Vitamin B₁₂ possessing binding activity to Castle'"'"'s intrinsic factor.

Claims

1. A complex for oral delivery of a substance to the circulation or lymphatic drainage system of a host, comprising the substance, a microparticle and a carrier, wherein:

said substance is entrapped or encapsulated in said microparticle and therein is not deleteriously affected by intestinal digestive substances following oral administration of said complex to the host;

said microparticle is a microsphere or microcapsule having a diameter of 1 nanometer to 150 micrometers and is coupled to said carrier by covalent bond, hydrophobic interaction or both;

said carrier is Vitamin B₁₂ or a Vitamin B₁₂ -analogue that binds Castle'"'"'s intrinsic factor and said carrier is effective to transport said complex via the intestinal mucosal epithelium into the circulation or lymphatic drainage system of the host, and

said substance is released from said microparticle into the circulation or lymph after said complex is transported via the intestinal mucosal epithelium into the circulation or lymphatic drainage system of the host.

3. A process for the production of a complex of claim 1, from a microparticle microsphere or microcapsule having a diameter of 1 nanometer to 150 micrometers and a carrier Vitamin B₁₂ or a Vitamin B₁₂ -analogue that binds Castle'"'"'s intrinsic factor, said process comprising one or more of the steps of:

(a) reacting said microparticles with said carrier molecule to form said complex;

(b) chemically modifying said carrier to form at least one functional group capable of forming a chemical linkage with said microparticle and then reacting the chemically modified carrier to form the complex;

(c) reacting said microparticle with at least one cross-linking agent and then with a carrier thereby linking said microparticle and carrier together in a complex;

(d) reacting said carrier with at least one cross-linking agent and then with said microparticle thereby linking said carrier molecule and said microparticle together in a complex;

(e) reacting said microparticle and said carrier with at least one cross-linking agent to form said complex;

(f) reacting said microparticle with at least one cross-linking agent, reacting said carrier with at least one cross-linking agent, and then reacting the products of said reactions to form said complex;

or

(g) reacting said carrier with a hydrophobic moiety and then reacting the product of this reaction with said microparticle to form a complex in which the carrier and microparticle are bonded together non-covalently by hydrophobic interaction.

5. A complex according to claim 1, wherein the microsphere or microcapsule entraps or encapsulates a hormone, drug, immunogen, ribozyme, DNA or RNA.

7. A complex according to claim 1, wherein the covalent bonding is by a cross-linking agent.

8. A composition for oral delivery of a substance or substances to the circulation or lymphatic drainage system of a host, comprising at least one complex according to claim 1.

9. A composition according to claim 8, further comprising a physiologically acceptable carrier, diluent, excipient or adjuvant.

10. A composition for oral delivery of a substance to the circulation or lymphatic drainage system of a host, comprising a complex of claim 1, together with a physiologically acceptable carrier, diluent, excipient or adjuvant.

11. A composition according to claim 9 or 10, wherein the carrier, diluent, excipient or adjuvant is orally and pharmaceutically acceptable.

12. A method of orally delivering a substance to the circulation or lymphatic drainage system of a host requiring such substance, comprising:

orally administering to the host an effective amount of a complex according to claim 1.

14. A method according to claim 12, wherein the host is a vertebrate.

15. A method according to claim 12, wherein said complex comprises a compound selected from the group consisting of a hormone, drug, immunogen, DNA or RNA.

2. A complex for oral delivery of a substance to the circulation or lymphatic drainage system of a host, comprising the substance, a microparticle and a carrier, wherein:

said substance can be entrapped or encapsulated in said microparticle and therein is not deleteriously affected by intestinal digestive substances following oral administration of said complex to the host;

said microparticle is a microsphere or microcapsule having a diameter of 1 nanometer to 150 micrometers and is coupled to said carrier by covalent bond, hydrophobic interaction or both;

said carrier is Vitamin B₁₂ or a Vitamin B₁₂ -analogue that binds Castle'"'"'s intrinsic factor and said carrier can transport said complex via the intestinal mucosal epithelium into the circulation or lymphatic drainage system of the host, and

said microparticle can release said substance into the circulation or lymph after said complex is transported via the intestinal mucosal epithelium into the circulation or lymphatic drainage system of the host.

6. A complex according to claim 2, wherein the microsphere or microcapsule is capable of entrapping or encapsulating a compound selected from the group consisting of a hormone, drug, immunogen, DNA or RNA.

13. A method of orally delivering a substance to the circulation or lymphatic drainage system of a host requiring such substance, comprising:

orally administering to the host an effective amount of a complex according to claim 2.

4. A kit for preparing a complex for oral delivery of a substance to the circulation or lymphatic drainage system of a host, comprising:

(A) at least one microparticle microsphere or microcapsule having a diameter of 1 nanometer to 150 micrometers;

(B) a substance entrapped or encapsulated in said microparticle whereby said substance is not deleteriously affected by intestinal digestive substances when said complex is administered orally to a host and said substance is released from said microparticle into the circulation or lymph when said complex enters the circulation or lymphatic drainage system of the host;

(C) at least one carrier Vitamin B₁₂ or a Vitamin B₁₂ -analogue molecule that binds Castle'"'"'s intrinsic factor and is effective to transport a complex via the intestinal mucosal epithelium into the circulation or lymphatic drainage system of the host;

(D) one or more reagents to couple said microparticle to said carrier by covalent bond, hydrophobic interaction or both to form a complex, wherein said reagents can couple said microparticle to said carrier to form a complex which, upon oral administration, is transported via the intestinal mucosal epithelium into the circulation or lymphatic drainage system and releases said substance into the circulation or lymph of said host.